44 research outputs found
Image-guided thermal ablation of central renal tumors with retrograde cold pyeloperfusion technique: a monocentric experience
Purpose: To evaluate feasibility, safety and efficacy of image-guided thermal ablations associated with retrograde pyeloperfusion in patients with centrally located renal tumors. Materials and methods: 48 patients (15 women, 33 men, mean age 69.1 ± 11.8) were treated with image-guided thermal ablation associated with pyeloperfusion for 58 centrally located renal tumors (mean diameter 32.3 ± 7.32 mm). 7 patients had a single kidney. Microwave and radiofrequency ablation were used. All treatments were performed with ultrasound, CT, or fusion imaging guidance under general anesthesia and simultaneous retrograde cold pyeloperfusion technique. Results: Procedure was feasible in all cases. Technical success and primary technical efficacy were reached in 51/58 (88%) and 45/54 tumors (83%). With a second ablation performed in 5 tumors, secondary technical efficacy was achieved in 50/50 (100%) tumors. Minor and major complications occurred in 8/58 (13%) and 5/58 (8%) tumors. No significative change in renal function occurred after treatment. During follow-up, 5 recurrences occurred, that were retreated with a second ablation. At last follow up (mean 32.2 ± 22.0 months), 41/48 (85%) treated patients were free from disease. The median TTP and PFS were 27.0 (range, 2.3–80.0) and 26.5 months (range, 2.3–80.0), respectively. Conclusion: Image-guided thermal ablation associated with protective pyeloperfusion is a feasible, safe, and effective treatment option for patients with central renal tumors with a minimal impact on renal function and relevant potential to avoid nephrectomy
Comparison between percutaneous and laparoscopic microwave ablation of hepatocellular carcinoma
Background: Based on patient and tumor characteristics, some authors favor laparoscopic microwave ablation (LMWA) over the percutaneous approach (PMWA) for treatment of hepatocellular carcinoma (HCC). We compared the two techniques in terms of technique efficacy, local tumor progression (LTP) and complication rates. Study design: A retrospective comparative analysis was performed on 91 consecutive patients (102 HCC tumors) who underwent PMWA or LMWA between October 2014 and May 2019. Technique efficacy at one-month and LTP at follow-up were assessed by contrast-enhanced CT/MRI. Kaplan–Meier estimates and Cox regression were used to compare LTP-free survival (LTPFS). Results: At baseline analysis, LMWA group showed higher frequency of multinodular disease (p < .001) and average higher energy delivered over tumor size (p = .033); PMWA group showed higher rates of non-treatment-naïve patients (p = .001), patients with Hepatitis-C (p = .03) and BCLC-A1 disease (p = .006). Technique efficacy was not significantly different between the two groups (p = .18). Among effectively treated patients, 75 (83 tumors) satisfied ≥6 months follow-up, 54 (57 tumors) undergoing PMWA and 21 (26 tumors) LMWA. LTP occurred in 14/83 cases (16.9%): 12 after PMWA (21.1%) and 2 after LMWA (7.7%). At univariate analysis, technique did not correlate to LTPFS (p = .28). Subgroup analysis showed a trend toward worse LTPFS after PMWA of subcapsular tumors (p = .16). Major complications were observed in six patients (6.6%), 2 after PMWA and 4 after LMWA (3.2% vs 14.3%, p = .049). Conclusions: Technical approach did not affect LTPFS. Complications were reported more frequently after LMWA. Despite higher complication rates, LMWA seems a valid option for treatment of subcapsular tumors
Real-Time US-CT fusion imaging for guidance of thermal ablation in of renal tumors invisible or poorly visible with US: results in 97 cases
Purpose To assess the capability of ultrasound-computed tomography (US-CT) fusion imaging to guide a precise targeting of renal tumors invisible or poorly visible with US Materials and methods From 2016 renal tumors poorly visible or inconspicuous/invisible at US were treated at our institution with the guidance of US/CT fusion in a room equipped with CT scanner. Feasibility of the procedure, accuracy of targeting, complications, and technique efficacy were evaluated. Results Of 227 patients treated from 2016 to March 2020, 91 patients (65 males and 26 females, mean age 68.5 ± 10.1 years) with 97 renal lesions (mean maximum diameter 21.6 ± 9.4 mm) inconspicuous/invisible (29/97, 29.9%) or poorly visible (68/97, 70.1%) at US underwent treatment under US-CT fusion guidance. US-CT fusion imaging guidance was always technically feasible and enabled correct targeting in 97/97/(100%) of cases. Technical success was achieved in 93/97 lesions (95.9%). Three lesions were retreated during the same ablative session, while 1 was retreated in a subsequent session. Thus, primary efficacy was achieved in one session in 96/97 (98.9%) cases and secondary efficacy in 97/97 (100%) cases Conclusion US-CT image fusion guidance allows for a correct tumor targeting of renal tumors poorly visible or inconspicuous/invisible with US alone, with a high rate of technical success and technique efficacy
Benign splenosis mimicking peritoneal seeding in a bladder cancer patient: a case report
This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens
Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients
<p>Abstract</p> <p>Background</p> <p>This study evaluates the surgical morbidity and long-term outcome of colorectal cancer surgery in an unselected group of patients treated over the period 1994–2003.</p> <p>Methods</p> <p>A consecutive series of 902 primary colorectal cancer patients (489 M, 413 F; mean age: 63 years ± 11 years, range: 24–88 years) was evaluated and prospectively followed in a university hospital (mean follow-up 36 ± 24 months; range: 3–108 months). Perioperative mortality, morbidity, overall survival, curative resection rates, recurrence rates were analysed.</p> <p>Results</p> <p>Of the total, 476 colorectal cancers were localized to the colon (CC, 53%), 406 to the rectum (RC, 45%), 12 (1%) were multicentric, and 8 were identified as part of HNPCC (1%). Combining all tumours, there were 186 cancers (20.6%) defined as UICC stage I, 235 (26.1%) stage II, 270 (29.9%) stage III and 187 (20.6%) stage IV cases. Twenty-four (2.7%) cases were of undetermined stage. Postoperative complications occurred in 38% of the total group (37.8% of CC cases, 37.2% of the RC group, 66.7% of the synchronous cancer patients and 50% of those with HNPCC, p = 0.19) Mortality rate was 0.8%, (1.3% for colon cancer, 0% for rectal cancer; p = 0.023). Multivisceral resection was performed in 14.3% of cases. Disease-free survival in cases resected for cure was 73% at 5-years and 72% at 8 years. The 5- and 8-year overall survival rates were 71% and 61% respectively (total cases). At 5-year analysis, overall survival rates are 97% for stage I disease, 87% for stage II, 73% for stage III and 22% for stage IV respectively (p < 0.0001). The 5-year overall survival rates showed a marked difference in R0, R1+R2 and non resected patients (82%, 35% and 0% respectively, p < 0.0001). On multivariate analysis, resection for cure and stage at presentation but not tumour site (colon vs. rectum) were independent variables for overall survival (p < 0.0001).</p> <p>Conclusion</p> <p>A prospective, uniform follow-up policy used in a single institution over the last decade provides evidence of quality assurance in colorectal cancer surgery with high rates of resection for cure where only stage at presentation functions as an independent variable for cancer-related outcome.</p
Non-surgical acute cholecystitis: 2 cases of gallbladder rupture after internal endoscopic or percutaneous diversion
Gallbladder rupture is a rare but serious complication of acute cholecystitis. We describe two cases of acute cholecystitis in patients not candidate for surgery that underwent internal biliary drainage with endoscopic and percutaneous approach, respectively. Both experienced gallbladder rupture in the postoperative period. The complication occurred after percutaneous internal drainage was treated conservatively, whereas the latter occurred after the endoscopic maneuver required an external percutaneous approach. After a brief revision of the literature about the interventional management of acute cholecystitis, the Authors discuss the possible reasons of galbladder rupture. </p
Embolization for the treatment of hypervascularized tumors
Hypervascular liver tumors include both hepatocellular carcinoma (HCC) and metastatic lesions from neuroendocrine tumors (NETs). Conspicuity of hepatic tumors on diagnostic imaging studies depends on adequate contrast with normal liver parenchyma. As well demonstrated previously, the hepatic artery has long been considered the predominant source of blood supply for liver tumors. HCC is one of the most vascular solid tumors in which angiogenesis plays an important role. The status of angiogenesis in HCC correlates with the disease progression and prognosis and, thus, provides a potential therapeutic target. Transarterial embolization (TAE) is a palliative treatment for patients with liver metastases from NETs, reducing hormonal symptoms and improving patients' survival. The rationale for transarterial treatments is based on the observations that both HCC and liver metastases from NETs are typically hypervascular deriving the majority of their blood supply from the hepatic artery. The TAE with microparticles should result in terminal vessel occlusion and blood flow obstruction. Microparticles should be very small, precisely and tightly calibrated just to be delivered into smaller peripheral arteries, and cause permanent ischemia. When using very small embolic agents two complications may occur: pulmonary embolism and nontarget embolization with reflux of embolization material. This article gives an overview on how to manage hypervascular liver tumors
Effect of color cues on attraction of <i>Lucilia sericata</i>.
<p>Mean proportions of 1-, 2-, and 3-day-old males and females captured in experiments 1–6 (<i>n</i> = 15 each; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0145055#pone.0145055.g001" target="_blank">Fig 1</a>) in inverted bottle traps (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0145055#pone.0145055.g002" target="_blank">Fig 2A</a>) that were baited with a generic floral scent (honey) and with a specific color cue (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0145055#pone.0145055.g002" target="_blank">Fig 2D</a>) covering the inner surface of the trap funnel. In each experiment, the number in parenthesis indicates the total number of flies captured, and an asterisk (*) on a bar indicates a significant preference for the test stimulus (Wilcoxon signed rank test, <i>p</i> < 0.05).</p